Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04786379 · ClinicalTrials.gov registry record · NA
Surgical Management of Knee Septic Arthritis
A NA study, sponsored by Texas Tech University Health Sciences Center, El Paso.
- Terminated
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT04786379 is a NA study that was terminated before completion, run by Texas Tech University Health Sciences Center, El Paso. The registered enrollment target is 10 participants.
The verdict
NCT04786379, a NA study, was terminated before completion, sponsored by Texas Tech University Health Sciences Center, El Paso.
- TERMINATED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
Surgical excisional debridement is the mainstay of management in septic arthritis with necessary decompression, lavage, debridement, and partial synovectomy. However, there has been considerable debate over the optimal modality. Most surgeons perform an open arthrotomy or arthroscopic debridement, although serial aspiration can be considered as an option in very limited circumstances with patients who cannot tolerate surgery. While open arthrotomy has been often utilized, there has been an increasing number of proponents for arthroscopic treatment citing lower re-infection rates and better functional outcomes. However, there has been a lack of well-designed prospective studies comparing surgical treatment modalities for native knee septic arthritis. The goals of this present study are to determine if arthroscopic management of septic arthritis in the native knee resulted in a lower number of surgeries and a shorter length of stay compared to open arthrotomy. Secondary outcomes included differences in postoperative pain and improvements in Lysholm knee scores.
Interventions
- PROCEDURE Arthroscopic Irrigation and Debridement
- PROCEDURE Open Arthrotomy with irrigation and debridement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2021-04-01 |
| Est. Completion | 2022-04-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04786379
The ClinicalTrials.gov registry entry for NCT04786379 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Texas Tech University Health Sciences Center, El Paso, which has 35 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Arthroscopic Irrigation and Debridement is the first listed.
NCT04786379 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04786379 about?
NCT04786379 is a clinical study titled "Surgical Management of Knee Septic Arthritis". Surgical excisional debridement is the mainstay of management in septic arthritis with necessary decompression, lavage, debridement, and partial synovectomy. However, there has been considerable debate over the optimal modality. Most surgeons perform an open arthrotomy or arthroscopic debridement, a...
What is the current status of trial NCT04786379?
This trial is currently terminated. It is a NA study. The enrollment target is 10 participants. The study started on 2021-04-01. Estimated completion is 2022-04-30.
What interventions are being tested in trial NCT04786379?
The interventions under investigation include: Arthroscopic Irrigation and Debridement (PROCEDURE), Open Arthrotomy with irrigation and debridement (PROCEDURE).
Who is sponsoring clinical trial NCT04786379?
This trial is sponsored by Texas Tech University Health Sciences Center, El Paso, which has 35 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.